Matching articles for "cancer screening"
Issue 1733 · July 21, 2025
Teal Wand — An At-Home Cervical Cancer Screening Device

The FDA has authorized use of Teal Wand (Teal Health), an at-home vaginal sample self-collection device, for cervical cancer screening.

Med Lett Drugs Ther. 2025 Jul 21; 67(1733):116 doi:10.58347/tml.2025.1733c
The FDA has authorized use of Teal Wand (Teal Health), an at-home vaginal sample self-collection device, for cervical cancer screening.
Issue 1730 · June 9, 2025
Shield — A Blood Test for Colorectal Cancer Screening

The FDA has approved Shield (Guardant), a DNA blood test, for colorectal cancer (CRC) screening in average-risk adults ≥45 years old. Shield is the second blood-based DNA test to be approved for CRC…

Med Lett Drugs Ther. 2025 Jun 9; 67(1730):90-2 doi:10.58347/tml.2025.1730b
The FDA has approved Shield (Guardant), a DNA blood test, for colorectal cancer (CRC) screening in average-risk adults ≥45 years old. Shield is the second blood-based DNA test to be approved for CRC screening; ColoHealth (formerly Epi proColon) was approved in 2016.
Issue 1728 · May 12, 2025
Cologuard Plus — An At-Home Stool DNA Test for Colorectal Cancer Screening

The FDA has approved Cologuard Plus (Exact Sciences), a new at-home multitarget stool DNA test, for colorectal cancer (CRC) screening in average-risk adults ≥45 years old. Cologuard , the first FDA-approved…

Med Lett Drugs Ther. 2025 May 12; 67(1728):73-5 doi:10.58347/tml.2025.1728a
The FDA has approved Cologuard Plus (Exact Sciences), a new at-home multitarget stool DNA test, for colorectal cancer (CRC) screening in average-risk adults ≥45 years old. Cologuard , the first FDA-approved multitarget stool DNA test, has been available since 2014.
Issue 1685 · September 18, 2023
Suflave — A Low-Volume Colonoscopy Preparation

The FDA has approved Suflave (Sebela/Braintree), a low-volume polyethylene glycol (PEG)- and sulfate-based product for cleansing of the colon prior to colonoscopy in adults. Other oral colonoscopy preparations…

Med Lett Drugs Ther. 2023 Sep 18; 65(1685):148-51 doi:10.58347/tml.2023.1685b
The FDA has approved Suflave (Sebela/Braintree), a low-volume polyethylene glycol (PEG)- and sulfate-based product for cleansing of the colon prior to colonoscopy in adults. Other oral colonoscopy preparations available in the US are listed in Table 2. Suflave is marketed as tasting better than other products.
Issue 1619 · March 8, 2021
Sodium Sulfate-Based Tablets (Sutab) for Colonoscopy Preparation

The FDA has approved an oral tablet formulation of sodium sulfate, magnesium sulfate, and potassium chloride ( Sutab – Braintree) for colon cleansing prior to colonoscopy in adults. A sodium sulfate-based…

Med Lett Drugs Ther. 2021 Mar 8; 63(1619):33-6
The FDA has approved an oral tablet formulation of sodium sulfate, magnesium sulfate, and potassium chloride ( Sutab – Braintree) for colon cleansing prior to colonoscopy in adults. A sodium sulfate-based oral solution (Suprep) has been available in the US since 2010. Sutab is the second tablet formulation to be approved for bowel cleansing prior to colonoscopy; a sodium phosphate-based tablet (OsmoPrep) was approved earlier.
Issue 1577 · July 29, 2019 Free
Correction: Plenvu

In our article in issue 1564 on Plenvu for colonoscopy preparation (Med Lett Drugs Ther 2019; 61:11) , the comparator drug in the DAYB trial was not Prepopik , but rather Citrafleet , a similar sodium…

Med Lett Drugs Ther. 2019 Jul 29; 61(1577):120
In our article in issue 1564 on Plenvu for colonoscopy preparation (Med Lett Drugs Ther 2019; 61:11) , the comparator drug in the DAYB trial was not Prepopik , but rather Citrafleet , a similar sodium picosulfate-based preparation that is not available in the US. Also, we said that Plenvu can be taken as a single- or split-dose regimen; we should have said that it can be taken as two doses in a single day or split over two days.
Issue 1575 · July 1, 2019
Colorectal Cancer Screening

Most colorectal cancers arise from localized adenomatous polyps in a process that may take 10 years or more. Early detection and removal of a precancerous colonic lesion (polyp) can prevent cancer from…

Med Lett Drugs Ther. 2019 Jul 1; 61(1575):97-9
Most colorectal cancers arise from localized adenomatous polyps in a process that may take 10 years or more. Early detection and removal of a precancerous colonic lesion (polyp) can prevent cancer from developing.
Issue 1564 · January 28, 2019
Plenvu - A Low-Volume PEG-Based Colonoscopy Preparation

The FDA has approved Plenvu (Salix), a polyethylene glycol (PEG)-containing oral powder for reconstitution, for colon cleansing prior to colonoscopy in adults. Plenvu is the first PEG-containing colonoscopy…

Med Lett Drugs Ther. 2019 Jan 28; 61(1564):11-4
The FDA has approved Plenvu (Salix), a polyethylene glycol (PEG)-containing oral powder for reconstitution, for colon cleansing prior to colonoscopy in adults. Plenvu is the first PEG-containing colonoscopy preparation that requires only 1 L of water for dissolution and ingestion of 1 L of clear fluid in addition.
Issue 1547 · May 21, 2018
Clenpiq - A Low-Volume Sodium Picosulfate-Based Colonoscopy Preparation

The FDA has approved Clenpiq (Ferring), a low-volume oral solution that contains sodium picosulfate, magnesium oxide, and anhydrous citric acid, for colon cleansing prior to colonoscopy in adults. The…

Med Lett Drugs Ther. 2018 May 21; 60(1547):84-6
The FDA has approved Clenpiq (Ferring), a low-volume oral solution that contains sodium picosulfate, magnesium oxide, and anhydrous citric acid, for colon cleansing prior to colonoscopy in adults. The ready-to-drink solution contains the same ingredients as Prepopik , which is supplied as a powder for reconstitution.
Issue 1453 · October 13, 2014
A Stool DNA Test (Cologuard) for Colorectal Cancer Screening

The FDA has approved Cologuard (Exact Sciences), a stool DNA test, to screen average-risk adults ≥50 years old for colorectal cancer.

Med Lett Drugs Ther. 2014 Oct 13; 56(1453):100-1
The FDA has approved Cologuard (Exact Sciences), a stool DNA test, to screen average-risk adults ≥50 years old for colorectal cancer.
Issue 1408 · January 21, 2013
Colonoscopy Preparations

Colonoscopy remains the preferred method of colorectal cancer screening. Many patients consider cleansing the bowel in preparation for colonoscopy the most unpleasant part of the procedure, but inadequate…

Med Lett Drugs Ther. 2013 Jan 21; 55(1408):6-7
Colonoscopy remains the preferred method of colorectal cancer screening. Many patients consider cleansing the bowel in preparation for colonoscopy the most unpleasant part of the procedure, but inadequate bowel preparation significantly lowers the diagnostic yield.
Issue 124 · December 1, 2012
Cancer Screening

Use of screening tests to identify cancers before they cause symptoms can lead to earlier therapy and may improve outcomes. Screening tests for some common cancers are reviewed below.

Treat Guidel Med Lett. 2012 Dec; 10(124):87-94
Use of screening tests to identify cancers before they cause symptoms can lead to earlier therapy and may improve outcomes. Screening tests for some common cancers are reviewed below.
Issue 1372 · September 5, 2011
Screening for Melanoma

In the absence of randomized studies demonstrating an impact on mortality, the US Preventive Services Task Force (USPSTF) has found the evidence insufficient to recommend a routine whole-body examination for…

Med Lett Drugs Ther. 2011 Sep 5; 53(1372):72
In the absence of randomized studies demonstrating an impact on mortality, the US Preventive Services Task Force (USPSTF) has found the evidence insufficient to recommend a routine whole-body examination for melanoma and other skin cancers.
Issue 1327 · December 14, 2009 Free
Screening Mammography for Women 40-49 Years Old

Conflicting recommendations on when to screen for breast cancer are problematic for healthcare providers. The recent recommendation by the US Preventive Services Task Force (USPSTF) against routine screening…

Med Lett Drugs Ther. 2009 Dec 14; 51(1327):97-8
Conflicting recommendations on when to screen for breast cancer are problematic for healthcare providers. The recent recommendation by the US Preventive Services Task Force (USPSTF) against routine screening mammography for women 40-49 years old conflicts with recommendations made by other organizations such as the American Cancer Society and earlier recommendations made by the USPSTF in 2002. Click here to view the free full article.
Issue 1303 · January 12, 2009 Free
Correction: CT Colonography

(Med Lett Drugs Ther 2008; 50:94) In Table 1, "Invasive" should be "less" and "more" rather than "no" and "yes" for CT colonography and colonoscopy, respectively. In the conclusion, CT colonography should be…

Med Lett Drugs Ther. 2009 Jan 12; 51(1303):4
(Med Lett Drugs Ther 2008; 50:94) In Table 1, "Invasive" should be "less" and "more" rather than "no" and "yes" for CT colonography and colonoscopy, respectively. In the conclusion, CT colonography should be changed to "less invasive" rather than "noninvasive".
Issue 1301 · December 15, 2008 Free
Correction: CT Colonography

(Med Lett Drugs Ther 2008; 50:94) In table 1, "Invasive" should be "less" and "more" rather than "no" and "yes" for CT colonography and colonoscopy, respectively.

Med Lett Drugs Ther. 2008 Dec 15; 50(1301):97-100
(Med Lett Drugs Ther 2008; 50:94) In table 1, "Invasive" should be "less" and "more" rather than "no" and "yes" for CT colonography and colonoscopy, respectively.
Issue 1300 · December 1, 2008
CT Colonography (Virtual Colonoscopy) Revisited

Options in screening for colon cancer include fecal occult blood tests, flexible sigmoidoscopy, colonoscopy, computed tomography (CT) colonography and fecal DNA tests. Since the last Medical Letter article on…

Med Lett Drugs Ther. 2008 Dec 1; 50(1300):94-5
Options in screening for colon cancer include fecal occult blood tests, flexible sigmoidoscopy, colonoscopy, computed tomography (CT) colonography and fecal DNA tests. Since the last Medical Letter article on this subject, more data have become available on colonography.
Issue 1298 · November 3, 2008
Prostate Cancer Screening

The US Preventive Services Task Force (USPSTF) has recently concluded that available evidence is insufficient to assess the balance between potential benefits and harms of using the prostate-specific antigen…

Med Lett Drugs Ther. 2008 Nov 3; 50(1298):85-6
The US Preventive Services Task Force (USPSTF) has recently concluded that available evidence is insufficient to assess the balance between potential benefits and harms of using the prostate-specific antigen (PSA) to screen men < 75 years old for prostate cancer and has recommended against screening men > 75 years old.
Issue 37 · September 1, 2005
Screening Tests for Cancer

Use of screening tests to identify cancers before they cause symptoms can lead to earlier therapy and may improve outcomes. Screening tests for some common cancers are reviewed.

Treat Guidel Med Lett. 2005 Sep; 3(37):63-8
Use of screening tests to identify cancers before they cause symptoms can lead to earlier therapy and may improve outcomes. Screening tests for some common cancers are reviewed.